Teva acquires Mexican Rimsa pharmaceutical for $2.3 billion
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is acquiring Rimsa, an independent pharmaceutical company in Mexico with a portfolio of products and patents in Latin America and Europe More...
Three Way Takeover Battle: Teva set to buy Allergan’s generics unit – WSJ
Teva likely mean the end of Teva’s pursuit of another Teva Pharmaceutical Industries Ltd. likely mean the end of pursuit of Mylan acquisition. The Israeli world’s biggest generic pharmaceutical maker More...
JPay Makes Tablet for Inmates
– – Would you believe that there is now a tablet made especially for prisoners? Well there is! Florida’s JPay has introduced the new Android based JP5mini, which comes with a clear cover More...
Teva CEO: The industry is undergoing a shakeup
“Size is important in the industry, but it isn’t everything. It’s important to be better. You have to make acquisitions that will suit the company’s strategic direction and contribute More...
The Durst Family is Getting into the Marijuana Business
– Alleged serial killer Robert Durst’s family is getting into the legal marijuana business. While Rob sits in prison awaiting trial on murder charges, his brother Douglas Durst is expanding the More...
Mylan to Teva: stop playing games with our company
Mylan reports that Teva Pharmaceutical Industries, which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake, but did not clarify which anti-trust rule More...
Three way takeover battle- Teva: We can close Mylan deal in 2015
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) CFO Eyal Desheh remains upbeat about Teva’s attempts to buy Mylan N.V. (Nasdaq: MYL). At the same time, Mylan continues to oppose the takeover More...
Actavis CEO: Teva-Mylan Deal to Create ‘Bad Blood’, Destroy Value
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of rival drug manufacturer Actavis, has raised concerns More...
Phillip Frost’s OPKO Health Acquires EirGen Pharma for $135 million in cash and shares
Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost, has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland, focused on the development and More...
Tamir Capital soars after court ruling against Teva
Shares in Tamir Capital are soaring on lively volumes, following a Tel Aviv District Court ruling that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) infringed the terms of a license from Proneuron More...